Low-dose droperidol suppresses transcranial electrical motor-evoked potential amplitude: a retrospective study.


Journal

Journal of clinical monitoring and computing
ISSN: 1573-2614
Titre abrégé: J Clin Monit Comput
Pays: Netherlands
ID NLM: 9806357

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 04 10 2019
accepted: 18 01 2020
pubmed: 19 2 2020
medline: 29 10 2021
entrez: 19 2 2020
Statut: ppublish

Résumé

Low-dose droperidol has been widely used as an antiemetic during and after surgery. Although high-dose droperidol affects motor-evoked potential, the effects of low-dose droperidol on motor-evoked potential amplitude are unclear. The aim of this study was to investigate whether low-dose droperidol affects motor-evoked potential amplitude. We retrospectively reviewed the data of patients who underwent spine surgery under general anesthesia with motor-evoked potential monitoring from February 2016 to 2017. The outcome was the motor-evoked potential amplitude of the bilateral abductor pollicis brevis muscle, tibialis anterior muscle, and abductor hallucis muscle within 1 and 1-2 h after droperidol administration, compared with the baseline motor-evoked potential value. Thirty-four patients were analyzed. The median dose of droperidol was 21 µg/kg. The motor-evoked potential amplitudes of all muscles were significantly reduced after droperidol administration and recovered to baseline values within 2 h. The reduction of all motor-evoked potential amplitudes after droperidol administration was 37-45% of baseline values. There were no significant differences in other drugs administered. There were no serious adverse effects of droperidol administration. Motor-evoked potential amplitude was suppressed by low-dose droperidol. During intraoperative motor-evoked potential monitoring in spine surgery, anesthesiologists should pay careful attention to the timing of administration of droperidol, even at low doses. Based on the results of this study, we are conducting a randomized controlled trial.

Identifiants

pubmed: 32067149
doi: 10.1007/s10877-020-00464-4
pii: 10.1007/s10877-020-00464-4
doi:

Substances chimiques

Droperidol O9U0F09D5X

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-181

Références

Schaub I, Lysakowski C, Elia N, Tramèr MR. Low-dose droperidol (≤ 1 mg or ≤ 15 µg kg
doi: 10.1097/EJA.0b013e328352813f pubmed: 22488335
Henzi I, Sonderegger J, Tramèr MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth. 2000;47:537–51. https://doi.org/10.1007/BF03018945 .
doi: 10.1007/BF03018945 pubmed: 10875717
Nuttall GA, Malone AM, Michels CA, Trudell LC, Renk TD, Marienau ME, Oliver WC, Ackerman MJ. Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient? Anesthesiology. 2013;118:382–6. https://doi.org/10.1097/ALN.0b013e31827dde8d .
doi: 10.1097/ALN.0b013e31827dde8d pubmed: 23291623
Gonzalez AA, Jeyanandarajan D, Hansen C, Zada G, Hsieh PC. Intraoperative neurophysiological monitoring during spine surgery: a review. Neurosurg Focus. 2009;27:E6. https://doi.org/10.3171/2009.8.FOCUS09150 .
doi: 10.3171/2009.8.FOCUS09150 pubmed: 19795955
Pelosi L, Lamb J, Grevitt M, Mehdian SM, Webb JK, Blumhardt LD. Combined monitoring of motor and somatosensory evoked potentials in orthopaedic spinal surgery. Clin Neurophysiol. 2002;113:1082–91. https://doi.org/10.1016/S1388-2457(02)00027-5 .
doi: 10.1016/S1388-2457(02)00027-5 pubmed: 12088704
Park P, Wang AC, Sangala JR, Kim SM, Hervey-Jumper S, Than KD, Farokhrani A, Lamarca F. Impact of multimodal intraoperative monitoring during correction of symptomatic cervical or cervicothoracic kyphosis. J Neurosurg Spine. 2011;14:99–105. https://doi.org/10.3171/2010.9.SPINE1085 .
doi: 10.3171/2010.9.SPINE1085 pubmed: 21142458
Langeloo DD, Lelivelt A, Journee HL, Louis Journée H, Slappendel R, de Kleuver M. Transcranial electrical motor-evoked potential monitoring during surgery for spinal deformity: a study of 145 patients. Spine. 2003;28:1043–50. https://doi.org/10.1097/01.BRS.0000061995.75709.78 .
doi: 10.1097/01.BRS.0000061995.75709.78 pubmed: 12768147
Nathan N, Tabaraud F, Lacroix F, Mouliès D, Viviand X, Lansade A, Terrier G, Feiss P. Influence of propofol concentrations on multipulse transcranial motor evoked potentials. Br J Anaesth. 2003;91:493–7. https://doi.org/10.1093/bja/aeg211 .
doi: 10.1093/bja/aeg211 pubmed: 14504148
Kalkman CJ, Drummond JC, Patel PM, Sano T, Chesnut RM. Effects of droperidol, pentobarbital, and ketamine on myogenic transcranial magnetic motor-evoked responses in humans. Neurosurgery. 1994;35:1066–71. https://doi.org/10.1227/00006123-199412000-00008 .
doi: 10.1227/00006123-199412000-00008 pubmed: 7885550
Saponaro González Á, Pérez Lorensu PJ, Chaves Gómez S, Nodarse Medina JF, Torres Dios J. What can we learn from two consecutive cases? Droperidol may abolish TcMEPs. Turk J Anaesthesiol Reanim. 2017;45:53–5. https://doi.org/10.5152/TJAR.2016.50336 .
doi: 10.5152/TJAR.2016.50336 pubmed: 28377841 pmcid: 5367726
Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KH, Hermann DJ, Muir KT, Mandema JW, Shafer SL. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86:10–23. https://doi.org/10.1097/00000542-199701000-00004 .
doi: 10.1097/00000542-199701000-00004 pubmed: 9009935
Kunisawa T, Nagashima M, Suzuki A, Takahata O, Iwasaki H. Calculating variable 'alpha' for predicting plasma concentrations of steady-state remifentanil. Anaesthesia. 2008;63:103–4. https://doi.org/10.1111/j.1365-2044.2007.05391.x .
doi: 10.1111/j.1365-2044.2007.05391.x pubmed: 18086090
Kunisawa T, Nagashima M, Suzuki A, Takahata O, Iwasaki H. The range of values of "variable alpha" when predicting plasma concentrations and/or effect site concentrations of remifentanil is huge. J Anesth. 2010;24:656–7. https://doi.org/10.1007/s00540-010-0961-y .
doi: 10.1007/s00540-010-0961-y pubmed: 20505958
Shafer SL, Siegel LC, Cooke JE, Scott JC. Testing computer-controlled infusion pumps by simulation. Anesthesiology. 1988;68:261–6. https://doi.org/10.1097/00000542-198802000-00013 .
doi: 10.1097/00000542-198802000-00013 pubmed: 3341578
Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology. 1990;73:1091–102. https://doi.org/10.1097/00000542-199012000-00005 .
doi: 10.1097/00000542-199012000-00005 pubmed: 2248388
Ghaly RF, Stone JL, Levy WJ, Kartha R, Brunner EA, Aldrete JA, Laege R. The effect of neuroleptanalgesia (droperiodol-fentanyl) on motor potentials evoked by transcranial magnetic stimulation in the monkey. J Neurosurg Anesthesiol. 1991;3:117–23. https://doi.org/10.1097/00008506-199106000-00006 .
doi: 10.1097/00008506-199106000-00006 pubmed: 15815390
Kobayashi S, Matsuyama Y, Shinomiya K, Kawabata S, Ando M, Kanchiku T, Saito T, Takahashi M, Ito Z, Muramoto A, Fujiwara Y, Kida K, Yamada K, Wada K, Yamamoto N, Satomi K, Tani T. A new alarm point of transcranial electrical stimulation motor evoked potentials for intraoperative spinal cord monitoring: a prospective multicenter study from the Spinal Cord Monitoring Working Group of the Japanese Society for Spine Surgery and Related Research. J Neurosurg Spine. 2014;20:102–7. https://doi.org/10.3171/2013.10.SPINE12944 .
doi: 10.3171/2013.10.SPINE12944 pubmed: 24236669
Cassady JF Jr, Lederhaas G, Cancel DD, Cummings RJ, Loveless EA. A randomized comparison of the effects of continuous thoracic epidural analgesia and intravenous patient-controlled analgesia after posterior spinal fusion in adolescents. Reg Anesth Pain Med. 2000;25:246–53.
pubmed: 10834778
O'Hara JF Jr, Cywinski JB, Tetzlaff JE, Xu M, Gurd AR, Andrish JT. The effect of epidural vs intravenous analgesia for posterior spinal fusion surgery. Paediatr Anaesth. 2004;14:1009–15. https://doi.org/10.1111/j.1460-9592.2004.01387.x .
doi: 10.1111/j.1460-9592.2004.01387.x pubmed: 15601351
Apfel CC, Cakmakkaya OS, Frings G, Kranke P, Malhotra A, Stader A, Turan A, Biedler A, Kolodzie K. Droperidol has comparable clinical efficacy against both nausea and vomiting. Br J Anaesth. 2009;103:359–63. https://doi.org/10.1093/bja/aep177 .
doi: 10.1093/bja/aep177 pubmed: 19605409
Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999;89:652–8.
doi: 10.1213/00000539-199911000-00030
Hamik A, Peroutka SJ. Differential interactions of traditional and novel antiemetics with dopamine D 2 and 5-hydroxytryptamine 3 receptors. Cancer Chemother Pharmacol. 1989;24:307–10. https://doi.org/10.1007/BF00304763 .
doi: 10.1007/BF00304763 pubmed: 2527092
Heyer EJ, Flood P. Droperidol suppresses spontaneous electrical activity in neurons cultured from ventral midbrain: implications for neuroleptanesthesia. Brain Res. 2000;863:20–4. https://doi.org/10.1016/S0006-8993(00)02066-7 .
doi: 10.1016/S0006-8993(00)02066-7 pubmed: 10773189
Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192:481–3. https://doi.org/10.1126/science.3854 .
doi: 10.1126/science.3854 pubmed: 3854
Flood P, Coates KM. Droperidol inhibits GABA(A) and neuronal nicotinic receptor activation. Anesthesiology. 2002;96:987–93. https://doi.org/10.1097/00000542-200204000-00029 .
doi: 10.1097/00000542-200204000-00029 pubmed: 11964609
Olschewski A, Bräu ME, Hempelmann G, Vogel W, Safronov BV. Differential block of fast and slow inactivating tetrodotoxin-sensitive sodium channels by droperidol in spinal dorsal horn neurons. Anesthesiology. 2000;92:1667–76. https://doi.org/10.1097/00000542-200006000-00026 .
doi: 10.1097/00000542-200006000-00026 pubmed: 10839918
Nakayama M, Kanaya N, Ichinose H, Yamamoto S, Namiki A. Intravenous droperidol causes a reduction in the bispectral index in propofol-sedated patients during spinal anesthesia. Anesth Analg. 2003;96:765–8. https://doi.org/10.1213/01.ANE.0000048517.98692.53 .
doi: 10.1213/01.ANE.0000048517.98692.53 pubmed: 12598260

Auteurs

Hiroyuki Deguchi (H)

Department of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan.

Kenta Furutani (K)

Department of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan. kenta-f@med.niigata-u.ac.jp.

Yusuke Mitsuma (Y)

Department of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan.

Yoshinori Kamiya (Y)

Department of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan.

Hiroshi Baba (H)

Department of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH